Sharps Technology Receives Purchase Orders For 1M SecureGard Syringes For 2024 Delivery
Portfolio Pulse from Benzinga Newsdesk
Sharps Technology, Inc. (NASDAQ: STSS) has received purchase orders for 1 million SecureGard ultra-low waste smart safety syringes from a Swiss-based provider of injectable therapies. The first 100k units will be shipped in late July, with the rest delivered throughout Q3 and Q4 of 2024. This marks the beginning of a potential long-term partnership.
July 03, 2024 | 5:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sharps Technology has received significant purchase orders for 1 million SecureGard syringes, indicating strong demand and potential for a long-term partnership with a major Swiss-based injectable therapy provider. This could positively impact revenue and market position.
The purchase orders for 1 million syringes from a major Swiss-based provider indicate strong demand for Sharps Technology's products. The initial shipment in July and subsequent deliveries throughout 2024 suggest a steady revenue stream. Additionally, the potential for a long-term partnership could further enhance Sharps' market position and revenue growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100